Problem
Unclear commercial pathway for a new diagnostics platform
Approach
Built GTM strategy and validated market demand through early partnerships
Outcome
"$6M funding supported by commercial validation"
Unclear commercial pathway for a new diagnostics platform
Built GTM strategy and validated market demand through early partnerships
"$6M funding supported by commercial validation"
Loss of market leadership and weak positioning
Rebuilt brand, messaging, and GTM strategy
"$12M+ revenue growth and renewed market presence"
Difficulty transitioning from service-based revenue to a scalable repeatable and predictable SAAS model.
Built investor-ready GTM positioning that transformed one-time credentialing services into a scalable intelligence SaaS platform.
"Doubled subscription revenue in 60 days while reducing manual LinkedIn engagement by 80% through smart automation."
Early-stage concept lacked scalable GTM
Built product positioning and commercial infrastructure
"Revenue growth and acquisition by Curi Bio"